Johnson & Johnson (JNJ) is Up 22% in 2025
Johnson & Johnson is one of the most iconic healthcare companies in the world, with a history that…
Novo Nordisk (NVO) Surges as Ozempic and Wegovy Drive $48.5B in 2025 Sales
Novo Nordisk A/S (NYSE:NVO) is a global healthcare leader with more than a century of history, founded in…
Summit Therapeutics (SMMT) Up 14% YTD
Summit Therapeutics Inc. (NASDAQ:SMMT) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies…
Anavex (AVXL) Could Surge 300%—Analyst Reiterates $42 Price Target
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for central nervous…
bioAffinity (BIAF) Soars 52% After CyPath Lung Detects Stage 1A Cancer
bioAffinity Technologies, Inc. (NASDAQ: BIAF) is a biotechnology company committed to transforming the diagnosis and treatment of cancer…
Sarepta (SRPT) Crashes 76% in 6 Months, But Gained $4.1B Sales
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biotechnology company that has built its reputation as a global leader in…
Praxis (PRAX) Plunges 37% After Tremor Drug Ulixacaltamide Trial Stopped for Futility
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous…
Jazz Pharma (JAZZ) Reports $905M R&D Charge, $505M Net Loss in Q2 2025
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, with a strong operational presence…
Harrow Health (HROW) Gains Momentum With $59 Cap on Out-of-Pocket Costs
Harrow Health Inc. (NASDAQ:HROW) is a U.S.-based ophthalmic pharmaceutical company that has steadily evolved from its roots in…
uniQure (QURE) Skyrockets 248% on Huntington’s Data
uniQure N.V. (NASDAQ:QURE) is a pioneering gene therapy company with a rich history of advancing cutting-edge treatments designed…
Immuneering (IMRX) Reports 86% 9-Month Survival in Pancreatic Cancer
Immuneering Corporation (NASDAQ:IMRX) is a clinical-stage oncology company headquartered in Cambridge, Massachusetts, that is pioneering a new class…
Qualigen Therapeutics (QLGN) Secures $41M Faraday Future Deal
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) is a clinical-stage biotechnology company based in Carlsbad, California, with a mission to develop…
BriaCell (BCTX) Raises $13.8M to Advance Cancer Immunotherapy Pipeline
BriaCell Therapeutics Corp. (NASDAQ:BCTX) is a clinical-stage biotechnology company advancing novel immunotherapies designed to transform cancer treatment. Founded…
PepGen (PEPG) Soars 96.8% After Breakthrough DM1 Results
PepGen Inc. (NASDAQ:PEPG) is a clinical-stage biotechnology company pioneering transformative therapies for neuromuscular and neurological diseases. Founded in…
Acadia Healthcare (ACHC) Down 71% in a Year
Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the largest dedicated providers of behavioral health services in the…
Soleno (SLNO) Oversold After 26% Drop
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies…
Acadia Pharmaceuticals (ACAD)’s Phase 3 Trial Fails
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company headquartered in San Diego, California, dedicated to advancing treatments for…
Cidara (CDTX) Soars on $516.9M Cash War Chest
Cidara Therapeutics Inc. (NASDAQ:CDTX) is a biotechnology company dedicated to the discovery, development, and commercialization of novel anti-infectives…